PCR12 Antibody

Shipped with Ice Packs
In Stock

Description

Target Overview: P2Y12 Receptor (P2RY12)

The P2Y12 receptor is a G-protein-coupled receptor (GPCR) critical in platelet activation and thrombosis. It binds adenosine diphosphate (ATP) and is a key therapeutic target for antiplatelet therapies .

Key Characteristics of P2RY12:

PropertyDescription
Gene SymbolP2RY12
Protein FunctionMediates platelet aggregation and thrombus stabilization
Tissue ExpressionPlatelets, microglia, eosinophils
Therapeutic RelevanceTarget for drugs like clopidogrel and ticagrelor

Anti-P2Y12 Receptor Antibody (APR-012)

The Anti-P2Y12 Receptor Antibody (#APR-012) is a well-characterized reagent for studying P2RY12 biology .

Research Applications

  • Flow Cytometry: Detects P2RY12 expression in human eosinophils .

  • Immunocytochemistry: Localizes P2RY12 in cellular compartments (e.g., membrane/cytoplasm) .

Experimental Validation

Key Findings from Muniz et al. (2015):

  • Demonstrated P2RY12 expression in eosinophils using APR-012 .

  • Preabsorption with blocking peptide abolished signal, confirming specificity .

Figure 1. Anti-P2Y12 Antibody Validation (Adapted from ):
![Figure 1](https://www.alomone.com/images/products/APR-012/ cytometry of human eosinophils. Right: Immunocytochemical staining (green = P2RY12).

Clinical and Therapeutic Context

While APR-012 itself is a research tool, P2RY12 inhibitors (e.g., clopidogrel) are widely used to prevent cardiovascular events. Studies suggest broader roles for P2RY12 in neuroinflammation and immune responses, highlighting its multidisciplinary relevance .

Limitations and Future Directions

  • Current data on APR-012 are primarily derived from in vitro models.

  • Further studies are needed to explore P2RY12’s role in non-platelet cell types (e.g., microglia in neurodegenerative diseases) .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
PCR12; At1g68630; F24J5.13; Protein PLANT CADMIUM RESISTANCE 12; AtPCR12
Target Names
PCR12
Uniprot No.

Target Background

Function
Putative involvement in heavy metal transport.
Database Links

KEGG: ath:AT1G68630

STRING: 3702.AT1G68630.1

UniGene: At.50012

Protein Families
Cornifelin family
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is PCR12 and why is it studied in plant research?

PCR12 is a protein found in Arabidopsis thaliana, a model organism widely used in plant molecular biology. The PCR12 gene (AT1G68630) encodes a protein that plays roles in plant cellular processes. Researchers study PCR12 to understand plant development, stress responses, and cellular signaling pathways. The PCR12 antibody enables detection and quantification of this protein in various experimental contexts. Antibodies against plant proteins like PCR12 are essential tools for advancing our understanding of plant biology at the molecular level .

What applications is the PCR12 antibody validated for?

The PCR12 antibody (CSB-PA890464XA01DOA-2) has been validated for ELISA (Enzyme-Linked Immunosorbent Assay) and WB (Western Blot) applications in plant samples. These techniques allow researchers to detect and quantify PCR12 protein in complex biological samples. The antibody is an affinity-purified rabbit polyclonal antibody raised against recombinant Arabidopsis thaliana PCR12 protein. Each antibody preparation typically includes 2mg of purified antibody along with positive control antigens (200μg) and pre-immune serum as a negative control .

How does a polyclonal PCR12 antibody differ from monoclonal alternatives?

Polyclonal PCR12 antibodies, like CSB-PA890464XA01DOA-2, contain a mixture of antibodies that recognize multiple epitopes on the PCR12 protein. This characteristic provides advantages in certain research contexts:

CharacteristicPolyclonal PCR12 AntibodyMonoclonal Antibody
Epitope recognitionMultiple epitopesSingle epitope
Signal strengthGenerally stronger signalsMay have lower sensitivity
Tolerance to protein denaturationMore tolerantLess tolerant
Batch-to-batch variationHigherLower
Production methodImmunization of rabbits or other animalsHybridoma technology
CostGenerally lowerGenerally higher

Polyclonal antibodies like the PCR12 antibody are particularly useful for detecting low-abundance proteins and for applications where protein may be partially denatured (such as Western blotting) .

How should PCR12 antibody be stored and handled to maintain optimal activity?

For optimal performance and longevity of the PCR12 antibody:

  • Store the antibody at -20°C or -80°C as recommended by the manufacturer

  • Avoid repeated freeze-thaw cycles by aliquoting the antibody before freezing

  • When handling, keep the antibody on ice

  • Centrifuge briefly before opening the vial to collect all material at the bottom

  • For dilutions, use high-quality buffers (typically PBS with 0.1% BSA or similar carrier protein)

  • For long-term storage solutions, consider adding preservatives like sodium azide (0.02%) to prevent microbial growth

Proper storage and handling are critical for maintaining antibody activity and ensuring reproducible experimental results .

What are the recommended dilutions and blocking conditions for PCR12 antibody in Western blotting?

While the optimal working dilution should be determined empirically for each application and experimental system, typical starting dilutions for polyclonal antibodies in Western blotting range from 1:200 to 1:1000. Based on the information available for similar antibodies:

  • Initial dilution recommendation: 1:400 for Western blotting

  • Blocking: 5% non-fat dry milk or 3-5% BSA in TBST (Tris-buffered saline with 0.1% Tween-20)

  • Primary antibody incubation: Overnight at 4°C or 1-2 hours at room temperature

  • Secondary antibody: Anti-rabbit IgG conjugated with HRP at 1:5000 dilution

  • Detection: Enhanced chemiluminescence (ECL) substrate

Always include proper controls, including the provided pre-immune serum as a negative control and the provided antigen as a positive control to validate specificity .

How can I validate the specificity of PCR12 antibody in my experimental system?

Validating antibody specificity is critical for ensuring reliable results. For PCR12 antibody:

  • Positive control: Use the provided antigen (200μg) as a positive control

  • Negative control: Include the pre-immune serum provided with the antibody as a negative control

  • Knockout/knockdown validation: If available, test the antibody on samples from PCR12 knockout or knockdown plants

  • Peptide competition assay: Pre-incubate the antibody with excess PCR12 recombinant protein or peptide before application to samples; specific signals should be reduced or eliminated

  • Molecular weight verification: Confirm that the detected band matches the predicted molecular weight of PCR12

  • Cross-reactivity assessment: Test the antibody on samples from different plant species to determine specificity within the plant kingdom

Thorough validation ensures that the observed signals truly represent PCR12 and not non-specific binding .

Why might Western blot results with PCR12 antibody show multiple bands, and how should they be interpreted?

Multiple bands in Western blots using PCR12 antibody could result from several factors:

  • Post-translational modifications: PCR12 protein may undergo modifications like phosphorylation or glycosylation, resulting in altered migration patterns

  • Protein isoforms: Alternative splicing may generate different PCR12 isoforms

  • Proteolytic degradation: Sample preparation without proper protease inhibitors may lead to degradation products

  • Non-specific binding: The polyclonal nature of the antibody may result in some cross-reactivity with similar proteins

To address and interpret multiple bands:

  • Include appropriate positive controls using recombinant PCR12 protein

  • Perform peptide competition assays to identify specific PCR12 bands

  • Use freshly prepared samples with protease inhibitors to minimize degradation

  • Consider using higher antibody dilutions to reduce non-specific binding

  • Optimize blocking conditions to minimize background signals

Careful analysis of band patterns across different samples and controls will help distinguish specific PCR12 signals from artifacts .

What are common pitfalls in PCR12 antibody-based experiments and how can they be avoided?

Common challenges and solutions in PCR12 antibody experiments include:

ChallengePotential CausesSolutions
Weak or no signalInsufficient protein, degraded antibody, incorrect dilutionsIncrease protein loading, verify antibody activity, optimize dilutions
High backgroundInsufficient blocking, excessive antibody, poor washingIncrease blocking time/concentration, dilute antibody further, extend wash steps
Non-specific bandsCross-reactivity, sample degradationUse peptide competition, add protease inhibitors, optimize antibody dilution
Variable results between experimentsInconsistent transfer, variable sample preparationStandardize protocols, include loading controls, use consistent exposure times
False positivesNon-specific bindingInclude appropriate negative controls, perform validation experiments

Maintaining consistent experimental conditions and including proper controls are essential for generating reliable and reproducible results .

How can I quantify PCR12 protein levels accurately using this antibody?

For accurate quantification of PCR12 protein levels:

  • Western blot quantification:

    • Include a standard curve using recombinant PCR12 protein at known concentrations

    • Use appropriate loading controls (e.g., actin or tubulin) for normalization

    • Ensure signal detection is within the linear range of your imaging system

    • Use image analysis software for densitometry analysis

  • ELISA quantification:

    • Develop a standard curve using the provided antigen at different concentrations

    • Run samples in triplicate to account for technical variation

    • Include appropriate positive and negative controls

    • Use statistical analyses to determine significance of observed differences

  • General considerations:

    • Minimize sample handling to reduce protein degradation

    • Maintain consistent experimental conditions across all samples

    • Validate results with complementary approaches (e.g., mRNA quantification)

    • Consider biological replicates to account for natural variation

How can PCR12 antibody be utilized in co-immunoprecipitation to study protein-protein interactions?

Co-immunoprecipitation (Co-IP) using PCR12 antibody can reveal protein interaction partners:

  • Sample preparation:

    • Extract proteins under non-denaturing conditions to preserve native interactions

    • Use mild detergents (e.g., 0.5% NP-40 or 1% Triton X-100) in the lysis buffer

    • Include protease and phosphatase inhibitors to prevent degradation

  • Immunoprecipitation procedure:

    • Pre-clear lysates with Protein A/G beads to reduce non-specific binding

    • Incubate lysates with PCR12 antibody (typically 2-5 μg per mg of protein)

    • Capture antibody-protein complexes with Protein A/G beads

    • Wash thoroughly to remove non-specifically bound proteins

    • Elute bound proteins and analyze by Western blot or mass spectrometry

  • Controls:

    • Negative control: Pre-immune serum or IgG from the same species

    • Input control: Analysis of total lysate before immunoprecipitation

    • Validation: Confirm interactions with reciprocal Co-IPs when possible

This approach can identify novel interaction partners of PCR12 protein, providing insights into its functional roles in plant cells .

What considerations are important when using PCR12 antibody for immunohistochemistry in plant tissues?

While the PCR12 antibody (CSB-PA890464XA01DOA-2) is not specifically validated for immunohistochemistry in the available information, researchers might adapt it for this purpose with these considerations:

  • Tissue preparation:

    • Fixation method significantly impacts epitope preservation (test paraformaldehyde, glutaraldehyde, or combinations)

    • Consider antigen retrieval methods to expose epitopes that may be masked during fixation

    • Section thickness affects antibody penetration (typically 5-10 μm for paraffin sections)

  • Protocol optimization:

    • Test a range of antibody dilutions (starting with 1:50 to 1:200)

    • Extend incubation times (overnight at 4°C may improve signal)

    • Include blocking steps with normal serum from the secondary antibody species

    • Use detergents (0.1-0.3% Triton X-100) to improve antibody penetration

  • Controls and validation:

    • Include sections without primary antibody

    • Use pre-immune serum as a negative control

    • Consider peptide competition assays to confirm specificity

    • When possible, compare with known expression patterns from in situ hybridization

Proper sample preparation and protocol optimization are critical for successful immunohistochemistry with PCR12 antibody in plant tissues .

How can PCR12 antibody be integrated into multi-omics approaches to study plant responses to environmental stresses?

Integrating PCR12 antibody-based assays into multi-omics studies can provide comprehensive insights into plant stress responses:

  • Proteomics integration:

    • Use PCR12 antibody for immunoprecipitation followed by mass spectrometry to identify post-translational modifications and interaction partners under stress conditions

    • Compare PCR12 protein levels (via Western blot) with global proteome changes from mass spectrometry

  • Transcriptomics correlation:

    • Correlate PCR12 protein levels with PCR12 gene expression data from RNA-Seq

    • Identify discrepancies between transcriptomic and proteomic data that may indicate post-transcriptional regulation

  • Metabolomics connections:

    • Correlate PCR12 protein abundance with changes in specific metabolites to infer functional relationships

    • Use PCR12 knockout/knockdown plants to identify metabolic pathways affected by PCR12 function

  • Data integration strategies:

    • Develop temporal profiles of PCR12 expression at protein and mRNA levels during stress responses

    • Use network analysis to position PCR12 within stress response pathways

    • Apply machine learning approaches to predict stress conditions based on PCR12 expression patterns

This integrated approach can reveal the functional significance of PCR12 in plant stress responses and identify potential applications in crop improvement .

What are the considerations for using PCR12 antibody in chromatin immunoprecipitation (ChIP) studies?

If PCR12 is suspected to interact with DNA or chromatin-associated proteins, ChIP assays using PCR12 antibody might be considered:

  • Experimental design considerations:

    • Cross-linking optimization: Test different formaldehyde concentrations (typically 1-3%) and incubation times

    • Sonication parameters: Optimize to achieve chromatin fragments of 200-500 bp

    • Antibody amount: Typically 3-5 μg per ChIP reaction (may require empirical determination)

    • Positive controls: Include antibodies against known DNA-binding proteins

    • Negative controls: Pre-immune serum and IgG controls are essential

  • Protocol adaptations:

    • For plant tissues, additional cell wall disruption steps may be necessary

    • Consider dual cross-linking with disuccinimidyl glutarate (DSG) and formaldehyde for proteins not directly binding DNA

    • Include plant-specific protease inhibitors in all buffers

  • Data analysis:

    • Design primers for PCR/qPCR validation targeting predicted binding regions

    • Consider whole genome approaches (ChIP-seq) to identify all potential binding sites

    • Use bioinformatics tools to identify DNA motifs enriched in immunoprecipitated regions

  • Validation strategies:

    • Confirm direct DNA binding with electrophoretic mobility shift assays (EMSA)

    • Validate functional significance through reporter gene assays

    • Correlate binding with gene expression changes

These approaches can determine if PCR12 has direct or indirect roles in transcriptional regulation during plant development or stress responses .

How does PCR12 antibody detection compare with antibody-based detection systems for other plant proteins?

When comparing PCR12 antibody-based detection with other plant protein detection systems:

  • Sensitivity comparison:

    • PCR12 polyclonal antibodies typically offer good sensitivity due to recognition of multiple epitopes

    • Sensitivity often depends on protein abundance; highly abundant proteins generally show better detection limits

    • Amplification systems (such as biotin-streptavidin) can improve detection for low-abundance proteins

  • Specificity considerations:

    • Cross-reactivity with related plant proteins may occur with polyclonal antibodies

    • Specificity challenges are common across plant research antibodies due to evolutionary conservation

    • Validation across multiple plant species is important to establish specificity boundaries

  • Technical comparison table:

Detection SystemTypical SensitivitySpecificityCommon ApplicationsLimitations
PCR12 AntibodyNanogram rangeSpecies-specificWB, ELISAMay cross-react with homologs
Anti-plant hormone antibodiesPicogram rangeVariableELISA, IHCHigh cross-reactivity concerns
Anti-photosystem protein antibodiesNanogram rangeHighly conservedWB, IHCOften cross-react across species
Anti-transcription factor antibodiesVariableOften specificChIP, EMSAOften low abundance targets
  • Methodological adaptations:

    • Plant-specific extraction methods are critical for all plant protein antibodies

    • Removal of interfering compounds (phenolics, pigments) is essential for clean results

    • Sample preparation protocols often need customization based on plant species and tissue type

Understanding these comparative aspects helps researchers select appropriate controls and validation strategies for PCR12 antibody applications .

How can antibody-based measurements of PCR12 complement genetic approaches to studying its function?

Integrating antibody-based PCR12 detection with genetic approaches creates a powerful research strategy:

  • Complementary insights:

    • Genetic approaches (knockouts, RNAi, CRISPR) reveal phenotypic consequences of PCR12 absence

    • Antibody-based approaches show where and when PCR12 protein is expressed

    • Combining both approaches can reveal post-transcriptional regulation mechanisms

  • Applications in genetic studies:

    • Confirming knockout/knockdown efficiency at protein level

    • Examining ectopic expression in overexpression lines

    • Analyzing protein stability and turnover in different genetic backgrounds

    • Detecting unexpected compensation by related proteins in mutant lines

  • Experimental strategy integration:

Genetic ApproachComplementary Antibody ApplicationResearch Insight Gained
CRISPR knockoutWestern blot confirmationVerify complete protein loss
RNAi knockdownQuantitative ELISAMeasure knockdown efficiency
Inducible expressionTime-course Western blotDetermine protein induction kinetics
Domain mutationsCo-IP with PCR12 antibodyIdentify domains required for protein interactions
Promoter fusionsComparison with IHCValidate reporter gene accuracy
  • Data interpretation advantages:

    • Distinguishing between transcriptional and post-transcriptional effects

    • Identifying cases where protein persists despite mRNA changes

    • Understanding protein localization changes in different genetic backgrounds

This integrated approach provides more complete understanding of PCR12 function than either approach alone .

What are emerging techniques that might enhance PCR12 antibody applications in plant research?

Several emerging technologies offer potential to expand PCR12 antibody applications:

  • Advanced microscopy applications:

    • Super-resolution microscopy for precise subcellular localization

    • FRET (Förster Resonance Energy Transfer) to study protein-protein interactions in vivo

    • Live-cell imaging using fluorescently-tagged secondary antibodies in permeabilized cells

  • Multiplex detection systems:

    • Simultaneous detection of PCR12 and other proteins using differentially labeled secondary antibodies

    • Single-cell proteomics approaches to analyze PCR12 expression in individual plant cells

    • Imaging mass cytometry for spatial proteomics applications

  • Proximity labeling approaches:

    • Antibody-guided enzymatic tagging (APEX, BioID) for identifying spatial protein networks

    • Targeted proximity proteomics to identify proteins co-localizing with PCR12

  • High-throughput applications:

    • Antibody arrays for analyzing PCR12 across multiple samples simultaneously

    • Automated immunostaining platforms for standardized detection

    • Machine learning approaches for image analysis of PCR12 localization patterns

These emerging approaches may allow researchers to address more complex questions about PCR12 function in plant biology .

What methodological considerations are important when evaluating conflicting PCR12 antibody results?

When faced with conflicting results using PCR12 antibody:

  • Technical factors to evaluate:

    • Antibody lot-to-lot variation: Different production batches may have different characteristics

    • Sample preparation differences: Extraction methods significantly impact protein detection

    • Detection system sensitivity: ECL substrates vary widely in sensitivity and dynamic range

    • Protocol variations: Small differences in blocking, washing, or incubation can affect outcomes

  • Experimental design considerations:

    • Controls: Verify all appropriate controls were included in both experiments

    • Quantification methods: Different image analysis approaches may yield different results

    • Statistical analysis: Ensure appropriate statistical tests were applied to determine significance

    • Biological versus technical replicates: Distinguish between experiment-to-experiment variation and true biological differences

  • Resolution strategies:

    • Independent verification using alternative methods (e.g., mass spectrometry)

    • Side-by-side comparison using standardized protocols

    • Validation with genetic approaches (knockout/knockdown)

    • Cross-laboratory validation with shared materials

  • Documentation and reporting recommendations:

    • Record detailed methodological information including antibody lot numbers

    • Include representative images of full blots including molecular weight markers

    • Report all validation experiments performed

    • Consider pre-registration of experimental protocols to reduce bias

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.